Suppr超能文献

集落刺激因子3及其受体促进胃癌中白细胞免疫球蛋白样受体B2的表达及配体。

Colony-stimulating factor 3 and its receptor promote leukocyte immunoglobulin-like receptor B2 expression and ligands in gastric cancer.

作者信息

Wang Long, Wu Qi, Zhang Zong-Wen, Zhang Hui, Jin Hui, Zhou Xin-Liang, Liu Jia-Yin, Li Dan, Liu Yan, Fan Zhi-Song

机构信息

Department of Oncology, The Fourth Hospital of Hebei Medical University, Shijiazhuang 050011, Hebei Province, China.

出版信息

World J Gastrointest Oncol. 2025 Feb 15;17(2):97858. doi: 10.4251/wjgo.v17.i2.97858.

Abstract

BACKGROUND

Colony-stimulating factor 3 (CSF3) and its receptor (CSF3R) are known to promote gastric cancer (GC) growth and metastasis. However, their effects on the immune microenvironment remain unclear. Our analysis indicated a potential link between CSF3R expression and the immunosuppressive receptor leukocyte immunoglobulin-like receptor B2 (LILRB2) in GC. We hypothesized that CSF3/CSF3R may regulate LILRB2 and its ligands, angiopoietin-like protein 2 (ANGPTL2) and human leukocyte antigen-G (HLA-G), contributing to immunosuppression.

AIM

To investigate the relationship between CSF3/CSF3R and LILRB2, as well as its ligands ANGPTL2 and HLA-G, in GC.

METHODS

Transcriptome sequencing data from The Cancer Genome Atlas were analyzed, stratifying patients by CSF3R expression. Differentially expressed genes and immune checkpoints were evaluated. Immunohistochemistry (IHC) was performed on GC tissues. Correlation analyses of CSF3R, LILRB2, ANGPTL2, and HLA-G were conducted using The Cancer Genome Atlas data and IHC results. GC cells were treated with CSF3, and expression levels of LILRB2, ANGPTL2, and HLA-G were measured by quantitative reverse transcriptase-polymerase chain reaction and western blotting.

RESULTS

Among 122 upregulated genes in high CSF3R expression groups, LILRB2 showed the most significant increase. IHC results indicated high expression of LILRB2 (63.0%), ANGPTL2 (56.5%), and HLA-G (73.9%) in GC tissues. Strong positive correlations existed between CSF3R and LILRB2, ANGPTL2, and HLA-G mRNA levels ( < 0.001). IHC confirmed positive correlations between CSF3R and LILRB2 ( < 0.001), and HLA-G ( = 0.010), but not ANGPTL2 ( > 0.05). CSF3 increased LILRB2, ANGPTL2, and HLA-G expression in GC cells. Heterogeneous nuclear ribonucleoprotein H1 modulation significantly altered their expression, impacting CSF3's regulatory effects.

CONCLUSION

The CSF3/CSF3R pathway may contribute to immunosuppression in GC by upregulating LILRB2 and its ligands, with heterogeneous nuclear ribonucleoprotein H1 playing a regulatory role.

摘要

背景

已知集落刺激因子3(CSF3)及其受体(CSF3R)可促进胃癌(GC)的生长和转移。然而,它们对免疫微环境的影响仍不清楚。我们的分析表明,GC中CSF3R表达与免疫抑制受体白细胞免疫球蛋白样受体B2(LILRB2)之间存在潜在联系。我们推测CSF3/CSF3R可能调节LILRB2及其配体血管生成素样蛋白2(ANGPTL2)和人类白细胞抗原G(HLA-G),从而导致免疫抑制。

目的

研究GC中CSF3/CSF3R与LILRB2及其配体ANGPTL2和HLA-G之间的关系。

方法

分析来自癌症基因组图谱的转录组测序数据,根据CSF3R表达对患者进行分层。评估差异表达基因和免疫检查点。对GC组织进行免疫组织化学(IHC)检测。使用癌症基因组图谱数据和IHC结果对CSF3R、LILRB2、ANGPTL2和HLA-G进行相关性分析。用CSF3处理GC细胞,通过定量逆转录聚合酶链反应和蛋白质免疫印迹法检测LILRB2、ANGPTL2和HLA-G的表达水平。

结果

在CSF3R高表达组的122个上调基因中,LILRB2的增加最为显著。IHC结果显示,GC组织中LILRB2(63.0%)、ANGPTL2(56.5%)和HLA-G(73.9%)高表达。CSF3R与LILRB2、ANGPTL2和HLA-G mRNA水平之间存在强正相关(<0.001)。IHC证实CSF3R与LILRB2(<0.001)和HLA-G(=0.010)之间存在正相关,但与ANGPTL2不存在正相关(>0.05)。CSF3增加了GC细胞中LILRB2、ANGPTL2和HLA-G的表达。不均一核核糖核蛋白H1调节显著改变了它们的表达,影响了CSF3的调节作用。

结论

CSF3/CSF3R通路可能通过上调LILRB2及其配体导致GC中的免疫抑制,不均一核核糖核蛋白H1起调节作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea3f/11756009/5406ea9084df/97858-g001.jpg

相似文献

3
Efficient expansion of mouse hematopoietic stem cells ex vivo by membrane anchored Angptl2.
Biochem Biophys Res Commun. 2022 Aug 20;617(Pt 1):42-47. doi: 10.1016/j.bbrc.2022.05.067. Epub 2022 May 31.
4
ANGPTL2 Induces Synovial Inflammation via LILRB2.
Inflammation. 2021 Jun;44(3):1108-1118. doi: 10.1007/s10753-020-01406-7. Epub 2021 Feb 4.
5
A motif in LILRB2 critical for Angptl2 binding and activation.
Blood. 2014 Aug 7;124(6):924-35. doi: 10.1182/blood-2014-01-549162. Epub 2014 Jun 4.
6
ANGPTL2/LILRB2 signaling promotes the propagation of lung cancer cells.
Oncotarget. 2015 Aug 28;6(25):21004-15. doi: 10.18632/oncotarget.4217.
8
An angiopoietin-like protein 2 autocrine signaling promotes EMT during pancreatic ductal carcinogenesis.
Oncotarget. 2015 May 30;6(15):13822-34. doi: 10.18632/oncotarget.2635.
10
LILRB2 promotes immune escape in breast cancer cells via enhanced HLA-A degradation.
Cell Oncol (Dordr). 2024 Oct;47(5):1679-1696. doi: 10.1007/s13402-024-00947-5. Epub 2024 Apr 24.

本文引用的文献

2
Cancer cell-intrinsic PD-1: Its role in malignant progression and immunotherapy.
Biomed Pharmacother. 2023 Nov;167:115514. doi: 10.1016/j.biopha.2023.115514. Epub 2023 Sep 15.
4
Prognostic significance of the immune checkpoint HLA-G/ILT-4 in the survival of patients with gastric cancer.
Int Immunopharmacol. 2022 Aug;109:108798. doi: 10.1016/j.intimp.2022.108798. Epub 2022 May 12.
5
The KEYNOTE-811 trial of dual PD-1 and HER2 blockade in HER2-positive gastric cancer.
Nature. 2021 Dec;600(7890):727-730. doi: 10.1038/s41586-021-04161-3. Epub 2021 Dec 15.
6
Long-Term Outcomes With Nivolumab Plus Ipilimumab or Nivolumab Alone Versus Ipilimumab in Patients With Advanced Melanoma.
J Clin Oncol. 2022 Jan 10;40(2):127-137. doi: 10.1200/JCO.21.02229. Epub 2021 Nov 24.
7
HLA-G/ILTs Targeted Solid Cancer Immunotherapy: Opportunities and Challenges.
Front Immunol. 2021 Jun 30;12:698677. doi: 10.3389/fimmu.2021.698677. eCollection 2021.
8
Prognostic Significance of Immune Checkpoints HLA-G/ILT-2/4 and PD-L1 in Colorectal Cancer.
Front Immunol. 2021 May 13;12:679090. doi: 10.3389/fimmu.2021.679090. eCollection 2021.
9
Tumor-derived ILT4 induces T cell senescence and suppresses tumor immunity.
J Immunother Cancer. 2021 Mar;9(3). doi: 10.1136/jitc-2020-001536.
10
Combinations using checkpoint blockade to overcome resistance.
Ecancermedicalscience. 2020 Dec 3;14:1148. doi: 10.3332/ecancer.2020.1148. eCollection 2020.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验